The Anifrolumab PRIM Program
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Establishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related Fatigue
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Biomarkers in Inflammatory Rheumatic Diseases Diagnosis
- Status
- RECRUITING
- Phase
- N/A
Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia
- Status
- COMPLETED
- Phase
- N/A
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)
- Status
- WITHDRAWN
- Phase
- PHASE1
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
US Zamto-cel Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients With SLE
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE1
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
- Status
- RECRUITING
- Phase
- N/A
Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.
- Status
- RECRUITING
- Phase
- PHASE1
Different Aspects and Etiologies of Gastointestinal Bleeding in Patients With Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Safety of Administering Isoniazid to SLE Patients to Prevent TB
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE3
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
- Status
- RECRUITING
- Phase
- NA
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
- Status
- RECRUITING
- Phase
- PHASE4
ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
- Status
- RECRUITING
- Phase
- N/A